Abstract: This invention relates to novel corosolic acid analogs of the formula I, wherein R1, R2, R3, R4 and R5 are as indicated below in each of said analogs: 1. R1=COCH3, R2=R3=R4=H, R5=COOH or R1, =R3=R4=H, R2=COCH3, R5=COOH 2. R1=R2=COCH3, R3=R4=H, R5=COOH 3. R1=COC5H4N, R2=R3=R4=H, R5=COOH 4. R1=COCH2NH2.HC1, R2=R3=R4=H, R5=COOH 5. R1=COCH2(CH3)NH2.HC1, R2=R3=R4=H, R5=COOH 6. R1=COCH:CHC6H2(OCH3)3, R2=R3=R4=H, R5=COOCH3 7. R1 & R2=S02, R3=R4=H, R5=COOH 8. R1=R2=R3=R4=H, R5=CONH2 9. R1=R2=R3=R4=H, R5=CONHC6H5 10. R1=R2=R3=R4=H, R5=CONHCH2CH2NH2 11. R1=R2=R3=R4=H, R5=CON(CH2CH2)2NH 12. R1=R2=R3=R4=H, R5=CONHCH2CH20H 13. R1=R2=R3=R4=H, R5=COOCH3 14. R1=R2=COCH3, R3=R4=H, R5=COOCH3 15. R1=R2=H, R3 & R4=0, R5=COOCH3 16. R1=R2=COCH3, R3 & R4=0, R5=COOCH3 17. R1=R2=H, R3 & R4=0, R5=COOH 18. R1=R2=COCH3, R3 & R4=0, R5=COOH 19. R1 & R2=S02, R3 & R4=0, R5=COOH 20. R1=R2=H, R3 & R4=0, R5=CONH2 21. R1=R2=R3=H, R4=OH, R5=CONH2 22. R1=R2=R3=H, R4=OH, R5=COOCH3 23. R1=R2=R3=R4=H, R5=CH20H 24.

Abstract: This invention relates to novel double salt of (?)-hydroxycitric acid with an amine and zinc or a group II A metal. These compounds are stable and water soluble and are used as nutraceuticals, weight reducing agents and in beverages. The double salts have the following general formula (I) Wherein X is zinc or a metal belonging to group II A of the Periodic Table and Y is glucosamine, caffeine or a known anorexic amine residue.

Abstract: This invention relates to novel triple salts of (?)-hydroxycitric acid having the general formula 1 wherein X, Y are selected from zinc or group IIA metal and Z is selected from group IA metal of the Periodic Table. Preferred salts are triple metal salts of calcium, magnesium or zinc and potassium. This invention also includes a process for preparing the triple salts by adding stiochiometric amounts of aqueous solutions of the compounds of the desired metal to an aqueous solution of (?)-HCA. Preferably an extract from garcinia fruit ring is used as a starting material. Compounds of this invention are substantially tastless, odourless and highly water soluble and find use in beverages and in neutraceuticals.

Abstract: This invention relates to new double salts of (?)-hydroxycitric acid with group II metals. Preferred double salts are calcium and magnesium double salts of hydroxycitric acid of the formula II. This invention also includes a process for the preparation of these double salts by the addition of one metal compound from group II to (?)-hydroxycitric acid solution followed by the addition of other metal compound solution from group II. These double salts are tasteless and are soluble in water. They are useful as dietary supplements and in beverages.

Abstract: This invention relates to a dietary supplement which is a phytochemical composition. This composition is capable of controlling inflammatory conditions and preventing and curing cancer in mammals. The composition comprises a synergistic mixture of standardized Boswellia extract, salts of glucosamine, and curcuminoids optionally containing bromelain, chondroitin, methylsulphonylmethane, resveratrol, extracts of white Willow and ginger, and quercetin.

Abstract: The present invention relates to dietary supplement phytochemical compositions, comprising calcium, potassium double salt of (?)-hydroxycitric acid and glucosamine hydrochloride, and optionally boswellic acids, curcuminoids, 5-hydroxytryptophan, chondroitin sulfate and L-carnitine. The claimed compositions are useful in dietary supplements, nutritional supplements or pharmaceutical preparations for weight loss and inflammatory epidemics.

Abstract: The invention relates to extraction concentration and separation of fractions containing Bacosides A and B from plant materials of Bacopa species. The dried plant materials are subjected to alcoholic or hydroalcoholic or water extraction and concentration of the extract. This solid mass is washed with a nonpolar organic solvent to remove fatty materials therefrom. The solid obtained thereafter is extracted with an organic polar solvent, the solvent extract is washed with water to remove water soluble contaminants therefrom and then dried in vacuum. This factor which is enriched with Bacosides A and B is subjected repeated chromatographic separation and purification to obtain Bacoside A and Bacoside B therefrom.

Abstract: The invention relates to an improved process for producing pharmacologically active synthetic stereoisomeric mixture of guggulsterones (4) in the three steps. The mixture of gugguisterones consists of Z-guggulsterone [4,17(20)-trans-pregnadiene-3,16-dione] and E-guggulsterone [4,17(20)-cis-pregnadiene-3,16-dione] and could be in any relative ratio. This improved process comprises (a) epoxidation of 16-dehydropregnanolone acetate (1) with hydrogen peroxide (b) reduction of the so obtained epoxide (2) with hydrazine hydrate and (c) oxidation of the diol (3).